Steward Partners Investment Advisory’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-100
Closed -$268 3449
2022
Q4
$268 Hold
100
﹤0.01% 3239
2022
Q3
$0 Hold
100
﹤0.01% 3448
2022
Q2
$0 Hold
100
﹤0.01% 3427
2022
Q1
$1K Hold
100
﹤0.01% 3248
2021
Q4
$2K Sell
100
-1,362
-93% -$29.4K ﹤0.01% 3051
2021
Q3
$29K Hold
1,462
﹤0.01% 2162
2021
Q2
$66K Sell
1,462
-50
-3% -$2.32K ﹤0.01% 2812
2021
Q1
$75.9K Sell
1,512
-691
-31% -$47.1K ﹤0.01% 1771
2020
Q4
$197K Buy
+2,203
New +$185K ﹤0.01% 1080

Other funds holding CELL

Steward Partners Investment Advisory's CELL Position: Q1 2023 in Review

Steward Partners Investment Advisory sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2023, closing a stake of 100 shares — an estimated $268 sold.

Steward Partners Investment Advisory first reported a position in CELL in Q4 2020 and held it in 9 quarters. The position peaked at $197K in Q4 2020. 102 funds tracked by Wall St. Rank hold CELL as of Q1 2023.

  • Steward Partners Investment Advisory reported no remaining PhenomeX Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 100 PhenomeX Inc. Common Stock shares in Q1 2023, an estimated $268.
  • Steward Partners Investment Advisory first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 9 quarters.
  • Steward Partners Investment Advisory's PhenomeX Inc. Common Stock position peaked at $197K in Q4 2020.
  • 102 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2023.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2023, filed 15 May 2023.